跳至主要内容
临床试验/NL-OMON37148
NL-OMON37148招募中不适用

Reduction of adverse effects by systemic antihistamines in drug therapy with fumarates in severe chronic plaque psoriasis: a doubleblind, randomized, placebo controlled clinical trial - Reduction of adverse effects of fumarates with antihistamines.

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1)Patients with known severe psoriasis of the chronic plaque type
  • 2)PASI >= 10
  • 3)Age >= 18 years
  • 4)Signed informed consent

排除标准

  • 1)Pregnancy and breast feeding
  • 2)Patients with Prostate hyperplasia, Glaucoma, Stomach ulcer
  • 3)Patients with liver diseases
  • 4)Patients with kidney diseases
  • 5)Patients with blood test deviations
  • 6)Patients with gastro-intestinal diseases
  • 7)Patients with a history of malignancies

研究者

相似试验